Lifeline Biotechnologies Market Cap

Lifeline Biotechnologies has a market cap or net worth of $2.61 million as of March 9, 2026. Its market cap has decreased by -60.00% in one year.

Market Cap

2.61M

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 2.61M, a decrease of -86.25%. That is a compound annual growth rate of -8.55%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	2.61M	-14.29%
Dec 31, 2025	3.04M	600.00%
Dec 31, 2024	434.89K	-35.07%
Dec 28, 2023	669.78K	-33.33%
Dec 30, 2022	1.00M	50.00%
Dec 31, 2021	669.78K	-60.00%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ludwig Enterprises	5.67M
ADM Tronics Unlimited	5.34M
Co-Diagnostics	5.26M
CYduct Diagnostics	3.90M
Vycor Medical	3.27M
Fuse Medical	2.82M
AI Maverick Intel	2.70M
Escalon Medical	1.71M

Market Cap Rankings